GGrantIndex
Sort

38,696 grants matching als

Developmental Transitions and Risk for Alcohol Use

$552,557
Gregory T. Smith · University Of Kentucky · R01 · FY2009 · AA

Functional studies of DICER1 and Alu RNA in geographic atrophy

$552,485
Jayakrishna Ambati · University Of Kentucky · R01 · FY2012 · EY

Training for Providers of an Evidence-Based AD Family Caregiver Intervention

$552,468
John V Hobday · Healthcare Interactive, Inc. · R44 · FY2012 · AG

Biobehavioral mechanisms of topiramate and drinking

$552,365
Peter M. Monti · Brown University · R01 · FY2009 · AA

CRAFT Behavior Therapy Phase 2 Study: Tx Entry Component

$552,359
Kimberly C Kirby · Treatment Research Institute · R01 · FY2007 · DA

Mapping the Genes for Ethanol Related Phenotypes

$552,311
Robert J Hitzemann · Oregon Health & Science University · R01 · FY2008 · AA

Theme C

$552,280
Lee S Bardwell · University Of California-Irvine · P50 · FY2008 · GM

Integrative Risk Reduction and Treatment for Teen Substance Use Problems and PTSD

$552,106
Carla Kmett Danielson · Medical University Of South Carolina · R01 · FY2015 · DA

Preclinical Development of Antisense Oligonucleotide Therapy for Spinocerebellar Ataxia Type 3

$552,105
Hayley Sarah McLoughlin · University Of Michigan At Ann Arbor · U01 · FY2020 · NS

Access, Preferences, and Costs for Alzheimer’s Disease Treatment in Alabama (AccessAL-AD)

$552,054
Maria Pisu · University Of Alabama At Birmingham · R33 · FY2025 · AG

SWW-IMPACTS: Scaling What Works -Improving and Accelerating Cancer Prevention, Treatment, and Survivorship

$551,926
Rachel Hirschey · Univ Of North Carolina Chapel Hill · U48 · FY2025 · DP

Developmental Phonological Disorders

$551,915
Lawrence D Shriberg · University Of Wisconsin-Madison · R01 · FY2015 · DC

Reducing Injury, ETOH &THC Use among ED Patients

$551,912
Rhode Island Hospital · R01 · FY2005 · AA

A Reinforcement Intervention for Increasing HIV Testing Among At-Risk Women

$551,827
Kristyn Zajac · University Of Connecticut Sch Of Med/Dnt · R01 · FY2021 · MD

Dysregulation of p97/VCP disease mutants in IBM and FTLD-U

$551,755
Tsui-Fen Chou · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R01 · FY2018 · NS

Using NIATx Strategies to Implement Integrated Services in Routine Care

$551,746
Mark P. McGovern · Stanford University · R01 · FY2017 · DA

Pre-Symptomatic Familial ALS (Pre-fALS) Study - Prelude to a Treatment Trial

$551,711
Michael Benatar · University Of Miami School Of Medicine · R01 · FY2021 · NS

The development and validation of a novel tool for the assessment of bulbar dysfunction in ALS

$551,619
Yana Yunusova · Sunnybrook Research Institute · R01 · FY2020 · DC

Tracking Risk Compensation Over Time in a National MC Roll-Out in Zimbabwe

$551,467
Daniel E Montano · Battelle Centers/Pub Hlth Res & Evaluatn · R01 · FY2012 · MH

Culture-Based Prediction of Adolescent HIV Risk

$551,460
Stephen L Eyre · University Of California, San Francisco · R01 · FY2010 · HD

Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases

$551,347
Patrizia Farci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI

Biomimetic Tactile Sensor for Prosthetics

$551,279
Jeremy Allan Fishel · Syntouch, Llc · R44 · FY2010 · HD

Biomimetic Tactile Sensor for Prosthetics

$551,279
Jeremy Allan Fishel · Syntouch, Llc · R44 · FY2011 · HD

Duration of Behavioral Counseling Treatment Needed to Optimize Smoking Abstinence

$551,275
Arthur Garvey · Harvard Medical School · R01 · FY2009 · DA

High-speed opto-fluidics to screen entire nervous system in aging and disease

$551,246
Adela Ben-Yakar · University Of Texas At Austin · R01 · FY2013 · AG